Hengkang Medical Group Co Ltd
SZSE:002219
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.69
3.32
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hengkang Medical Group Co Ltd
Hengkang Medical Group Co Ltd
Revenue
Hengkang Medical Group Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Revenue
¥3.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
19%
|
|
|
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
Revenue
¥4.1B
|
CAGR 3-Years
43%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Revenue
¥20.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
24%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Revenue
¥4.9B
|
CAGR 3-Years
24%
|
CAGR 5-Years
40%
|
CAGR 10-Years
3%
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Revenue
¥4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Revenue
¥1.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hengkang Medical Group Co Ltd
Glance View
Hengkang Medical Group Co. Ltd. is engaged in the manufacturing, sale, research and development of traditional Chinese medicines. The company is headquartered in Chengdu, Sichuan and currently employs 7,622 full-time employees. The company went IPO on 2008-03-06. In addition, The Company also engages in the research and development, production and manufacture of Chinese patent medicines, Chinese herbal medicines and Chinese medicinal materials, medical devices, medical institution preparations, daily chemicals and health products. The firm operates its business within the domestic market and overseas markets.
See Also
What is Hengkang Medical Group Co Ltd's Revenue?
Revenue
3.8B
CNY
Based on the financial report for Sep 30, 2024, Hengkang Medical Group Co Ltd's Revenue amounts to 3.8B CNY.
What is Hengkang Medical Group Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
19%
Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Hengkang Medical Group Co Ltd have been 8% over the past three years , and 19% over the past ten years .
You don't have any saved screeners yet
